返回 Agenda
Session Chair(s)
Milan Zdravkovic, MD
Senior Vice President, Head of Research & Development
Swedish Orphan Biovitrum AB, Sweden
Speaker(s)
An Analysis of Attrition Rates in Late-Stage Drug Development
Ke Zhang
Thomson Reuters, United Kingdom
Head of Segment
Martin Moller
McKinsey & Company, Denmark
Director
Does Partnering Have an Influence on Subsequent EMA Marketing Authorisations?
Cornelis A Van Den Bogert, PHARMD, MSC
Utrecht University, Netherlands